Frederique Ph.D. Menzaghi, Cara Therapeutics's VP-Research & Development, recently disposed of 6,000 shares of the company. The disposals took place at $14.26 per share, on November 02, 2015. Menzaghi still owns 147,000 shares of the company. Menzaghi operates out of Shelton, CT. Some additional info was provided as follows:
This sale was...